Informationssystem  
 
Sie sind hier:» Forschung » Informationssystem » Forschungsbericht » Verbundvorhaben
  • Print this page

Union of Light Ions Centres in Europe

ULICE
  EU Capacities: Research Infrastructure Project
Sprecher bzw. wiss. Koordinator Prof. Roberto Orecchia
Fondazione Centro Nazionale di Adroterapia Oncologica - Fondazione CNAO
Via Caminadella
Milano, Italien
Anzahl der Partner19
Marburger Teilnehmer Klinik für Strahlentherapie : Prof. Dr. Rita Engenhart-Cabilic
Laufzeit und Finanzierung 01.09.2009 - 30.07.2013
4 Jahre
Beschreibung ULICE is a 4-year project set up by 20 leading European research organisations, including 2 leading European industrial partners (Siemens and IBA), to respond to the need for greater access to hadron therapy facilities for particle therapy research.

Project coordinator is the Italian Research Infrastructure Facility CNAO (Milan). Both existing European Hadron Research Facilities in Heidelberg and Milan are partner and together with the next operational centre (Philipps-Universität Marburg; yr4) they will provide 624 hours of beam-time (141 users, 52 projects) to external researchers. Future facilities like MedAustron, Etoile and Archade also participate in ULICE, which will result in a strong integrated network. Full exploitation of all different resources, unrestricted spread of information and the improvement of existing and upcoming facilities are provided by using grid-based data sharing.

The project is built around 3 pillars with measurable outputs. These outputs will be exploited by the (future) facilities and (partly by) the industrial partners:
* JRA - focus on development of instruments and protocols: new gantry design, improvement of four-dimensional particle beam delivery, adaptive treatment planning, mechanisms for patient selection to the whole European Community and database development for specific tumours which can best be treated using carbon ion.
* Networking - increasing cooperation between facilities and research communities wanting to work with the research infrastructure. Outputs will be (among others): a report on recommendations for strategically optimal locations for future RIs throughout Europe, training to new users.
* Transnational access: 2-step approach, using a combination of pre-defined (within ULICE) clinical trial programmes to allow researchers with patients to visit the facility, and radiobiological and physics experiments to take place.

Externe Teilnehmer
D, GSI Helmholtzzentrum für Schwerionenforschung Gmbh, Darmstadt
D, Technische Universität Dresden
D, Universitätsklinikum Heidelberg
D, Siemens AG
A, Medizinische Universitaet Wien
A, EBG (Entwicklungs- und Betriebsgesellschaft) Medaustron GmbH, Wien
B, European Society for Therapeutic Radiology and Oncology, Brussels
B, Université catholique de Louvain, Louvain-la-Neuve
B, Ion Beam Applications S.A., Louvain-la-Neuve
CH, Organisation européenne pour la recherche nucléaire (CERN)
DK, Åarhus Universitetshospital, Åarhus Sygehus
F, GCS Centre Etoile, Lyon
GB, University of Oxford
I, Istituto Nazionale di Fisica Nucleare, Rome
NL, Stichting Katholieke Universiteit Nijmegen
PL, The Henryk NiewodniczaDski Institute of Nuclear Physics - Polish Academy of Sciences, Kraków
S, Karolinska Institutet, Stockholm

[Länderschlüssel]

Zuletzt aktualisiert: 28.10.2009

 
  Philipps-Universität Marburg

Forschungsbericht der Philipps-Universität Marburg

Impressum